International Union of Pharmacology. LXIII. Retinoid X receptors

被引:403
|
作者
Germain, Pierre
Chambon, Pierre
Eichele, Gregor
Evans, Ronald M.
Lazar, Mitchell A.
Leid, Mark
De Lera, Angel R.
Lotan, Reuben
Mangelsdorf, David J.
Gronemeyer, Hinrich
机构
[1] Univ Strasbourg 1, INSERM, CNRS, Inst Genet & Biol Mol & Cellulaire, Illkirch Graffenstaden, France
[2] Max Planck Inst Expt Endocrinol, Hannover, Germany
[3] Salk Inst Biol Studies, Howard Hughes Med Inst, Gene Express Lab, La Jolla, CA 92037 USA
[4] Univ Penn, Sch Med, Div Endocrinol Diabet & Metab, Dept Med, Philadelphia, PA 19104 USA
[5] Univ Penn, Sch Med, Inst Diabet Obes & Metab, Philadelphia, PA 19104 USA
[6] Oregon State Univ, Mol & Cellular Biol Program, Corvallis, OR 97331 USA
[7] Univ Vigo, Fac Quim, Dept Quim Organ, Vigo, Galicia, Spain
[8] Univ Texas, MD Anderson Canc Ctr, Dept Thorac Head & Neck Med Oncol, Unit 432, Houston, TX 77030 USA
[9] Univ Texas, SW Med Ctr, Dept Pharmacol, Howard Hughes Med Inst, Dallas, TX USA
关键词
D O I
10.1124/pr.58.4.7
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The physiological effects of retinoic acids (RAs) are mediated by members of two families of nuclear receptors, the retinoic acid receptors (RARs) and the retinoid X receptors (RXRs), which are encoded by three distinct human genes, RXR alpha, RXR beta, and RXR gamma. RARs bind both all-trans- and 9-cis-RA, whereas only the 9-cis-RA stereoisomer binds to RXRs. As RXR/RAR heterodimers, these receptors control the transcription of RA target genes through binding to RA-response elements. This review is focused on the structure, mode of action, ligands, expression, and pharmacology of RXRs. Given their role as common partners to many other members of the nuclear receptor superfamily, these receptors have been the subject of intense scrutiny. Moreover, and despite numerous studies since their initial discovery, RXRs remain enigmatic nuclear receptors, and there is still no consensus regarding their role. Indeed, multiple questions about the actual biological role of RXRs and the existence of an endogenous ligand have still to be answered.
引用
收藏
页码:760 / 772
页数:13
相关论文
共 50 条
  • [21] International Union of Pharmacology.: XX.: Current status of the nomenclature for nicotinic acetylcholine receptors and their subunits
    Lukas, RJ
    Changeux, JP
    Le Novère, N
    Albuquerque, EX
    Balfour, DJK
    Berg, DK
    Bertrand, D
    Chiappinelli, VA
    Clarke, PBS
    Collins, AC
    Dani, JA
    Grady, SR
    Kellar, KJ
    Lindstrom, JM
    Marks, MJ
    Quik, M
    Taylor, PW
    Wonnacott, S
    [J]. PHARMACOLOGICAL REVIEWS, 1999, 51 (02) : 397 - 401
  • [22] International Union of Pharmacology. LXV. The pharmacology and classification of the nuclear receptor superfamily: Glucocorticoid, mineralocorticoid, progesterone, and androgen receptors
    Lu, Nick Z.
    Wardell, Suzanne E.
    Burnstein, Kerry L.
    Defranco, Donald
    Fuller, Peter J.
    Giguere, Vincent
    Hochberg, Richard B.
    McKay, Lorraine
    Renoir, Jack-Michel
    Weigel, Nancy L.
    Wilson, Elizabeth M.
    McDonnell, Donald P.
    Cidlowski, John A.
    [J]. PHARMACOLOGICAL REVIEWS, 2006, 58 (04) : 782 - 797
  • [23] International union of pharmacology.: XXXV.: The glucagon receptor family
    Mayo, KE
    Miller, LJ
    Bataille, D
    Dalle, S
    Göke, B
    Thorens, B
    Drucker, DJ
    [J]. PHARMACOLOGICAL REVIEWS, 2003, 55 (01) : 167 - 194
  • [24] International Union of Pharmacology. XXXIV. Lysophospholipid receptor nomenclature
    Chun, J
    Goetzl, EJ
    Hla, T
    Igarashi, Y
    Lynch, KR
    Moolenaar, W
    Pyne, S
    Tigyi, G
    [J]. PHARMACOLOGICAL REVIEWS, 2002, 54 (02) : 265 - 269
  • [25] International Union of Basic and Clinical Pharmacology. XCIV. Adhesion G Protein-Coupled Receptors
    Hamann, Joerg
    Aust, Gabriela
    Arac, Demet
    Engel, Felix B.
    Formstone, Caroline
    Fredriksson, Robert
    Hall, Randy A.
    Harty, Breanne L.
    Kirchhoff, Christiane
    Knapp, Barbara
    Krishnan, Arunkumar
    Liebscher, Ines
    Lin, Hsi-Hsien
    Martinelli, David C.
    Monk, Kelly R.
    Peeters, Miriam C.
    Piao, Xianhua
    Proemel, Simone
    Schoeneberg, Torsten
    Schwartz, Thue W.
    Singer, Kathleen
    Stacey, Martin
    Ushkaryov, Yuri A.
    Vallon, Mario
    Wolfrum, Uwe
    Wright, Mathew W.
    Xu, Lei
    Langenhan, Tobias
    Schoeith, Helgi B.
    [J]. PHARMACOLOGICAL REVIEWS, 2015, 67 (02) : 338 - 367
  • [26] International Union of Basic and Clinical Pharmacology. XCIX. Angiotensin Receptors: Interpreters of Pathophysiological Angiotensinergic Stimuli
    Karnik, Sadashiva S.
    Unal, Hamiyet
    Kemp, Jacqueline R.
    Tirupula, Kalyan C.
    Eguchi, Satoru
    Vanderheyden, Patrick M. L.
    Thomas, Walter G.
    [J]. PHARMACOLOGICAL REVIEWS, 2015, 67 (04) : 754 - 819
  • [27] International Union of Basic and Clinical Pharmacology. LXXXI. Nomenclature and Classification of Adenosine Receptors-An Update
    Fredholm, Bertil B.
    IJzerman, Adriaan P.
    Jacobson, Kenneth A.
    Linden, Joel
    Mueller, Christa E.
    [J]. PHARMACOLOGICAL REVIEWS, 2011, 63 (01) : 1 - 34
  • [28] International Union of Pharmacology. XXXI. Recommendations for the nomenclature of multimeric G protein-coupled receptors
    Spedding, M
    Bonner, TI
    Watson, SP
    [J]. PHARMACOLOGICAL REVIEWS, 2002, 54 (02) : 231 - 232
  • [29] International Union of Basic and Clinical Pharmacology. LXXXIII: Classification of Prostanoid Receptors, Updating 15 Years of Progress
    Woodward, D. F.
    Jones, R. L.
    Narumiya, S.
    [J]. PHARMACOLOGICAL REVIEWS, 2011, 63 (03) : 471 - 538
  • [30] International union of pharmacology. LXVIII. Mammalian bombesin receptors: Nomenclature, distribution, pharmacology, signaling, and functions in normal and disease states
    Jensen, R. T.
    Battey, J. F.
    Spindel, E. R.
    Benya, R. V.
    [J]. PHARMACOLOGICAL REVIEWS, 2008, 60 (01) : 1 - 42